We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
-7.67%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$21.1B
AUM Growth
+$3.39B
(+19%)
Cap. Flow
+$5.28B
Cap. Flow
% of AUM
25.06%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
1,642
New
480
Increased
535
Reduced
285
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$365M |
| 2 |
Ambev
ABEV
|
+$276M |
| 3 |
Bank of America
BAC
|
+$234M |
| 4 |
Vodafone
VOD
|
+$227M |
| 5 |
Starbucks
SBUX
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$237M |
| 2 |
Nokia
NOK
|
+$212M |
| 3 |
Qualcomm
QCOM
|
+$189M |
| 4 |
AGN
Allergan plc
AGN
|
+$130M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.75% |
| 2 | Consumer Staples | 16.46% |
| 3 | Healthcare | 14.42% |
| 4 | Technology | 13.7% |
| 5 | Consumer Discretionary | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Berkshire Hathaway Class B
BRK.B
$1.11T
| $151M | 0.71% |
1,154,950
+686,324
| +146% | +$94M |
|
27
TJX Companies
TJX
$176B
| $150M | 0.71% |
4,209,002
+697,200
| +20% | +$24.4M |
|
28
MetLife
MET
$61.8B
| $150M | 0.71% |
3,557,861
+1,945,757
| +121% | +$90.9M |
|
|
29
Intel
INTC
$514B
| $140M | 0.67% |
4,655,624
-8,179,510
| -64% | -$237M |
|
30
HP
HPQ
$26.2B
| $138M | 0.65% |
11,836,507
+164,324
| +1% | +$2.13M |
|
|
AET
31
DELISTED
Aetna Inc
AET
| $136M | 0.65% |
1,247,420
+976,165
| +360% | +$113M |
|
|
SHPG
32
DELISTED
Shire pic
SHPG
| $136M | 0.64% |
660,286
+227,200
| +52% | +$54M |
|
33
Ulta Beauty
ULTA
$23.1B
| $128M | 0.61% |
785,345
+85,936
| +12% | +$14.1M |
|
34
GSK
GSK
$103B
| $125M | 0.59% |
2,594,802
+1,792,864
| +224% | +$93.3M |
|
35
Union Pacific
UNP
$176B
| $123M | 0.58% |
1,388,867
+701,068
| +102% | +$64M |
|
36
Novartis
NVS
$293B
| $123M | 0.58% |
1,488,320
+1,364,779
| +1,105% | +$121M |
|
37
Lincoln National
LNC
$8.89B
| $114M | 0.54% |
2,402,753
+253,800
| +12% | +$13.6M |
|
38
Lockheed Martin
LMT
$134B
| $109M | 0.52% |
524,773
+7,400
| +1% | +$1.51M |
|
39
Teva Pharmaceuticals
TEVA
$40.6B
| $107M | 0.51% |
1,897,468
-25,116
| -1% | -$1.63M |
|
40
F5
FFIV
$23.4B
| $106M | 0.5% |
919,012
-14,503
| -2% | -$1.78M |
|
41
Ameriprise Financial
AMP
$49.3B
| $104M | 0.49% |
954,337
+227,100
| +31% | +$26.8M |
|
|
CERN
42
DELISTED
Cerner Corp
CERN
| $103M | 0.49% |
1,714,845
+320,878
| +23% | +$21M |
|
|
RAI
43
DELISTED
Reynolds American Inc
RAI
| $101M | 0.48% |
2,276,838
+1,777,446
| +356% | +$73.7M |
|
44
CME Group
CME
$94.7B
| $96.1M | 0.46% |
1,035,972
+99,800
| +11% | +$9.49M |
|
45
Principal Financial Group
PFG
$24.4B
| $95.9M | 0.45% |
2,024,822
+438,900
| +28% | +$22.7M |
|
|
BRFS
46
DELISTED
BRF SA
BRFS
| $94M | 0.45% |
5,284,458
+3,861,005
| +271% | +$75.9M |
|
47
Walt Disney
DIS
$174B
| $92.2M | 0.44% |
901,691
-648,550
| -42% | -$70.6M |
|
48
Colgate-Palmolive
CL
$74B
| $91.8M | 0.44% |
1,447,163
+620,558
| +75% | +$40.5M |
|
49
General Motors
GM
$78.1B
| $90M | 0.43% |
2,996,774
+2,880,474
| +2,477% | +$88.2M |
|
|
EMC
50
DELISTED
EMC CORPORATION
EMC
| $87.3M | 0.41% |
3,611,939
+3,054,980
| +549% | +$77.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Arrowstreet Capital held 1,642 positions worth $21.1B, up 19% from $17.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital deployed $5.28B of net new capital in Q3 2015, opening 480 new positions and adding to 535 existing holdings. Its largest new stake was BP: 2,515,866 shares worth $64.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Intel, an estimated $237M trimmed.
- Arrowstreet Capital's largest Q3 2015 buy was BP: 2,515,866 shares worth $64.7M.
- Arrowstreet Capital added most to AB InBev in Q3 2015, an estimated $365M increase.
- Arrowstreet Capital's biggest Q3 2015 reduction was Intel, cutting an estimated $237M.
- Arrowstreet Capital fully exited Nokia in Q3 2015, selling an estimated $212M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $21.1B portfolio in Q3 2015.
- Arrowstreet Capital opened 480 new positions and closed 318 in Q3 2015.
- Arrowstreet Capital's portfolio value rose 19% quarter-over-quarter to $21.1B.
Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.